Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Aug:92:1073-1084.
doi: 10.1016/j.biopha.2017.06.007. Epub 2017 Jun 10.

Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases

Affiliations
Review

Cross-talk of MicroRNA and hydrogen sulfide: A novel therapeutic approach for bone diseases

Yuankun Zhai et al. Biomed Pharmacother. 2017 Aug.

Abstract

Bone homeostasis requires a balance between the bone formation of osteoblasts and bone resorption of osteoclasts to maintain ideal bone mass and bone quality. An imbalance in bone remodeling processes results in bone metabolic disorders such as osteoporosis. Hydrogen sulfide (H2S), a gasotransmitter, has attracted the focus of many researchers due to its multiple physiological functions. It has been implicated in anti-inflammatory, vasodilatory, angiogenic, cytoprotective, anti-oxidative and anti-apoptotic mechanisms. H2S has also been shown to exert osteoprotective activity through its anti-inflammatory and anti-oxidative effects. However, the underlying molecular mechanisms by which H2S mitigates bone diseases are not completely understood. Experimental evidence suggests that H2S may regulate signaling pathways by directly influencing a gene in the cascade or interacting with some other gasotransmitter (carbon monoxide or nitric oxide) or both. MicroRNAs (miRNAs) are short non-coding RNAs which regulate gene expression by targeting, binding and suppressing mRNAs; thus controlling cell fate. Certainly, bone remodeling is also regulated by miRNAs expression and has been reported in many studies. MicroRNAs also regulate H2S biosynthesis. The inter-regulation of microRNAs and H2S opens a new possibility for exploring the H2S-microRNA crosstalk in bone diseases. However, the relationship between miRNAs, bone development, and H2S is still not well explained. This review focuses on miRNAs and their roles in regulating bone remodeling and possible mechanisms behind H2S mediated bone loss inhibition, H2S-miRNAs crosstalk in relation to the pathophysiology of bone remodeling, and future perspectives for miRNA-H2S as a therapeutic agent for bone diseases.

Keywords: Bone remodeling; Hydrogen sulfide; Osteoblast; Osteoclast; Osteoporosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors have declared no conflict of interest.

Figures

Fig. 1
Fig. 1
The biogenesis of miRNAs. Pri-miRNAs are transcribed from intergenic genes and processed into a pre-miRNA by the Drosha/DGCR8 complex, creating a 70–80 nts, hairpin-looped molecule, which is then shuttled out of the nucleus via the exportin-5 mediated transportation. Cytoplasmatic digestion of the pre-miRNA is facilitated by Dicer, resulting in double-stranded mature miRNAs. Mature miRNAs modulate gene expression by RNA-induced silencing complex (RISC) which composed by the dicer, argonaute 2, and TRBP. If miRNAs perfectly base pairing with sequences in the target mRNAs, mRNA will deadenylation and decapping and then cleavage; alternatively, miRNAs could repressing the transcription of target mRNAs when the miRNAs incomplete matching with target mRNAs.
Fig. 2
Fig. 2
miRNAs regulate the key signal molecules during the osteoblast differentiation and osteoclastogenesis. PPARγ: peroxisome proliferator-activated receptor gamma; Dlx5: distal-less homeobox 5; BMPs: bone morphogenetic proteins; M-CSF: macrophage-colony stimulating factor; RANKL: receptor activator of NF-κB ligand.
Fig. 3
Fig. 3
Sulfide metabolism and transsulfuration pathways. Cystathionine β (CBS) and cystathionine γ-lyase (CSE) govern the flow of sulfur through homocysteine, cystathionine, and cysteine for the generating H2S in the cytosol. While the third way for H2S production via cysteine aminotransferase (CAT) and 3-mercaptopyruvate sulfurtransferase (3-MST). sulfide quinone oxidoreductase (SQOR) oxidizes H2S to glutathione persulfide (GSSH) with GSH as the electron acceptor or directly to thiosulfate (SO32−) using co-enzyme Q (Co-Q) as the electron acceptor. Both the production and oxidation of H2S were processed in the mitochondrion.
Fig. 4
Fig. 4
Physiological functions of H2S. Including anti-inflammatory, cytoprotective, anti-oxidative, anti-apoptosis, ATP generation, vasodilatation, and osteoprotective effects, even about crosstalk of miRNAs and H2S. During its osteoprotective processing, H2S stimulate the osteogenic differentiation markers (ALP, BGP, osteopontin) but inhibit osteoblast apoptosis, whereas, H2S could promote apoptosis of osteoclast, and inhibit osteoclast differentiation and maturation.

Similar articles

Cited by

References

    1. Larsson S, Fazzalari NL. Anti-osteoporosis therapy and fracture healing. Arch Orthop Trauma Surg. 2014;134(2):291–29. - PubMed
    1. Yang G, Wu L, Jiang B, Yang W, Qi J, Cao K, Meng Q, Mustafa AK, Mu W, Zhang S, Snyder SH, Wang R. H2S as a physiologic vasorelaxant: hypertension in mice with deletion of cystathionine gamma-lyase. Science. 2008;322(5901):587–590. - PMC - PubMed
    1. Grassi F, Malik Tyagi A, Calvert JW, Gambari L, Walker LD, Yu M, Robinson J, Li JY, Lisignoli G, Vaccaro C, Adams J, Pacifici R. Hydrogen Sulfide Is a Novel Regulator of Bone Formation Implicated in the Bone Loss Induced by Estrogen Deficiency. J Bone Miner Res: Official J Am Soc Bone Miner Res. 2016;31(5):949–963. - PMC - PubMed
    1. Li L, Rose P, Moore PK. Hydrogen sulfide and cell signaling. Annu Rev Pharmacool Toxicol. 2011;51:169–187. - PubMed
    1. Martin-Millan M, Almeida M, Ambrogini E, Han L, Zhao H, Weinstein RS, Jilka RL, O’Brien CA, Manolagas SC. The estrogen receptor-alpha in osteoclasts mediates the protective effects of estrogens on cancellous but not cortical bone. Mol Endocrinol. 2010;24(2):323–334. - PMC - PubMed